Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Operating Expenses | 71,703 | 53,126 | 63,071 | 51,727 | 36,841 |
| Operating Income | -71,703 | -53,126 | -63,071 | -51,727 | -36,841 |
| Interest Expense | 3,157 | 2,531 | 1,488 | 936 | 1,757 |
| Other Income | -504 | -3,322 | -1,491 | -499 | 86 |
| Pre-tax Income | -75,364 | -58,980 | -66,050 | -53,161 | -38,512 |
| Income Tax | 3 | 3 | 3 | 2 | -3,272 |
| Net Income Continuous | -75,367 | -58,983 | -66,052 | -53,163 | -35,240 |
| Net Income | $-75,367 | $-58,983 | $-66,052 | $-53,163 | $-35,240 |
| EPS Basic Total Ops | -4.06 | -4.72 | -6.20 | -7.00 | -13.40 |
| EPS Basic Continuous Ops | -4.06 | -4.72 | -6.23 | -6.96 | -9.71 |
| EPS Diluted Total Ops | -4.06 | -4.72 | -6.20 | -7.00 | -13.40 |
| EPS Diluted Continuous Ops | -4.06 | -4.72 | -6.23 | -6.96 | -9.71 |
| EPS Diluted Before Non-Recurring Items | -3.99 | -4.80 | N/A | -7.00 | -13.40 |
| EBITDA(a) | $-71,589 | $-53,082 | $-62,866 | $-51,465 | $-36,287 |